<code id='84240524E1'></code><style id='84240524E1'></style>
    • <acronym id='84240524E1'></acronym>
      <center id='84240524E1'><center id='84240524E1'><tfoot id='84240524E1'></tfoot></center><abbr id='84240524E1'><dir id='84240524E1'><tfoot id='84240524E1'></tfoot><noframes id='84240524E1'>

    • <optgroup id='84240524E1'><strike id='84240524E1'><sup id='84240524E1'></sup></strike><code id='84240524E1'></code></optgroup>
        1. <b id='84240524E1'><label id='84240524E1'><select id='84240524E1'><dt id='84240524E1'><span id='84240524E1'></span></dt></select></label></b><u id='84240524E1'></u>
          <i id='84240524E1'><strike id='84240524E1'><tt id='84240524E1'><pre id='84240524E1'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:7235

          Has AI really solved biology? What can machines teach us about medicine? And what’s a digital twin?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our all-AI episode. First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials. Then, we talk to Joel Dudley, a partner at the venture firm Innovation Endeavors, about how to discern promising ideas from wastes of time when it comes to AI in biotech.

          advertisement

          For more on what we cover, here’s the latest on AI in drug development; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          Wikipedia

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          FogPharma raises $145 million in rare Series E round
          FogPharma raises $145 million in rare Series E round

          FogPharmaCEOMathaiMammenBostonGlobePhotoImportOncologystartupFogPharmajustcloseda$145millionSeriesEr

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Sen. Bill Cassidy on how to lower drug prices

          AdobeInthe1952Oscar-winningmovie“HighNoon,”GaryCooper’sfacewastenseandpainedashesingle-handedlyfaced